Pacer Advisors
AZN icon

Pacer Advisors’s AstraZeneca AZN Stock Holding History

Pacer Advisors’s Portfolio AZN Stock Details AZN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-21,185
Closed -$3.89M – 2309
2025
Q4 		$3.89M Buy
21,185
+706
+3% +$124K 0.01% 803
2025
Q3 		$3.14M Sell
20,479
-1,418
-6% -$215K 0.01% 863
2025
Q2 		$3.06M Sell
21,897
-6,209
-22% -$870K 0.01% 861
2025
Q1 		$4.13M Buy
28,106
+385
+1% +$55.7K 0.01% 725
2024
Q4 		$3.63M Buy
27,721
+249
+0.9% +$34.9K 0.01% 749
2024
Q3 		$4.28M Sell
27,472
-53
-0.2% -$8.55K 0.01% 678
2024
Q2 		$4.29M Sell
27,525
-108
-0.4% -$16.3K 0.01% 629
2024
Q1 		$3.74M Sell
27,633
-254
-0.9% -$33.6K 0.01% 662
2023
Q4 		$3.76M Buy
27,887
+1,623
+6% +$211K 0.01% 627
2023
Q3 		$3.56M Buy
26,264
+4,107
+19% +$561K 0.01% 515
2023
Q2 		$3.17M Sell
22,157
-6,998
-24% -$1.03M 0.01% 614
2023
Q1 		$4.05M Buy
29,155
+8,876
+44% +$1.19M 0.02% 588
2022
Q4 		$2.75M Buy
20,279
+11,703
+136% +$1.47M 0.01% 518
2022
Q3 		$941K Buy
8,576
+224
+3% +$28.4K 0.01% 554
2022
Q2 		$1.1M Buy
+8,352
New +$1.1M 0.01% 526
2022
Q1 		– Sell
-11,749
Closed -$1.37M – 2286
2021
Q4 		$1.37M Sell
11,749
-146
-1% -$17.2K 0.01% 1019
2021
Q3 		$1.43M Buy
11,895
+1,625
+16% +$189K 0.02% 756
2021
Q2 		$1.23M Buy
10,270
+300
+3% +$32.9K 0.02% 773
2021
Q1 		$991K Sell
9,970
-866
-8% -$87.1K 0.02% 776
2020
Q4 		$1.08M Sell
10,836
-2,420
-18% -$256K 0.02% 663
2020
Q3 		$1.45M Buy
+13,256
New +$1.47M 0.03% 543
2020
Q1 		– Sell
-9,975
Closed -$995K – 699
2019
Q4 		$995K Buy
9,975
+2,951
+42% +$278K 0.04% 547
2019
Q3 		$626K Buy
7,024
+2,594
+59% +$225K 0.01% 950
2019
Q2 		$366K Buy
+4,430
New +$347K 0.01% 1013
2013
Q4 		$605K Buy
+8,594
New +$467K 0.15% 191

Other funds holding AZN

IA
Investor AB Stockholm, Sweden $15.1B AUM 29.02% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Legal & General Group
Legal & General Group London, United Kingdom $432B AUM 29.4% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
VAM
Vanguard Asset Management London, Ec4n 8af $117B AUM

Pacer Advisors's AZN Position: Q1 2026 in Review

Pacer Advisors sold out of AstraZeneca (AZN) in Q1 2026, closing a stake of 21,185 shares — an estimated $3.89M sold.

Pacer Advisors first reported a position in AZN in Q4 2013 and held it in 25 quarters. The position peaked at $4.29M in Q2 2024. 1,377 funds tracked by Wall St. Rank hold AZN as of Q1 2026.

  • Pacer Advisors reported no remaining AstraZeneca position as of Q1 2026 after selling out during the quarter.
  • Pacer Advisors sold 21,185 AstraZeneca shares in Q1 2026, an estimated $3.89M.
  • Pacer Advisors first reported a position in AstraZeneca in Q4 2013 and held it in 25 quarters.
  • Pacer Advisors's AstraZeneca position peaked at $4.29M in Q2 2024.
  • 1,377 funds tracked by Wall St. Rank held AstraZeneca as of Q1 2026.

Based on Pacer Advisors's 13F filing for Q1 2026, filed 6 May 2026.